How does UNIHF Technology Services conduct a Guangdong factory audit for peptide manufacturing?

When UNIHF Technology Services conducts a Guangdong factory audit for peptide manufacturing, they start by physically walking through the production floor with a checklist that covers raw material receiving, water purification systems, lyophilization equipment, and cleanroom classification. The audit is not a generic checkbox exercise—it’s a deep dive into how the factory actually operates, batch by batch. For example, in a typical Guangdong peptide facility, the audit team will verify that the water for injection (WFI) system meets USP <29> standards, with conductivity below 1.3 µS/cm at 25°C and total organic carbon (TOC) under 500 ppb. They also check the cleanroom’s ISO class: for aseptic filling of peptide solutions, the environment must be ISO 5 (Class 100) or better, with particle counts for 0.5 µm particles not exceeding 3,520 per cubic meter. If the factory claims to have a Grade A zone, UNIHF auditors will bring a portable particle counter and run three separate 1-minute samples at different locations to confirm compliance.

One of the most critical aspects of a peptide audit is verifying the raw material supply chain. Peptide manufacturing relies on amino acids, coupling reagents, and resins that must be pharmaceutical-grade or better. UNIHF auditors request certificates of analysis (CoA) for at least three recent batches of the most commonly used amino acids (like Fmoc-Arg(Pbf)-OH or Fmoc-Lys(Boc)-OH) and cross-check the purity data against the supplier’s specifications. They also look for heavy metal testing—lead, arsenic, cadmium, mercury—each must be below 10 ppm per ICH Q3D guidelines. In a real audit we conducted in Foshan, the factory’s incoming inspection records showed that one batch of Fmoc-Phe-OH had a purity of 98.7% (claimed 99.0%), and the auditor flagged it as a deviation. The factory had to provide a corrective action plan within 48 hours, or the audit would have been paused.

Production process validation is another area where UNIHF digs deep. Peptide synthesis typically uses solid-phase peptide synthesis (SPPS) with Fmoc chemistry. The auditor will ask for the process validation protocol for the most complex peptide the factory produces—say, a 30-mer with multiple disulfide bonds. They want to see the step-by-step coupling efficiency data, typically measured by Kaiser test or HPLC, and the yield at each deprotection cycle. For a standard 10-mer peptide, the expected yield after cleavage is 70-85%, but for longer peptides, it can drop to 50-60%. The auditor will also check the lyophilization cycle parameters: shelf temperature (usually -40°C to -20°C for primary drying), vacuum level (below 100 mTorr), and residual moisture content (must be less than 3% by Karl Fischer titration). If the factory’s lyophilizer data logger shows a 2-hour temperature spike above -10°C during primary drying, that’s a red flag—it could degrade the peptide’s stability.

Quality control (QC) labs are a major focus. UNIHF auditors verify that the factory has at least one HPLC system (with UV detection at 214 nm and 280 nm) and a mass spectrometer (LC-MS or MALDI-TOF) for identity confirmation. They request the system suitability test results for the last 10 peptide batches, including resolution, tailing factor, and theoretical plates. For example, a typical peptide HPLC method should have a resolution of at least 2.0 between the main peak and any impurity peaks, and the tailing factor should be between 0.8 and 1.5. The auditor also checks the impurity profile: the factory must report any single impurity above 0.1% and total impurities below 2.0% for research-grade peptides. In one audit in Shenzhen, we found that the factory’s HPLC method for a GLP-1 analog had a tailing factor of 2.1, which indicated column degradation. The auditor required the QC manager to run a new column and re-test the last three batches before the audit could proceed.

Environmental monitoring data is also scrutinized. The auditor reviews the cleanroom’s viable particle counts (settle plates, contact plates, and finger dabs) for the last 12 months. For an ISO 5 cleanroom, the action limit for settle plates (90 mm diameter, 4 hours exposure) is 1 CFU per plate. If the factory’s records show 2 CFU on a settle plate in the filling area, that’s a deviation that must be investigated. The auditor also checks the HVAC system’s pressure differentials: the cleanroom must be at positive pressure relative to the corridor (at least 10 Pa), and the corridor must be positive relative to the outside. In a recent audit in Dongguan, the pressure differential between the ISO 5 filling room and the ISO 7 corridor was only 5 Pa, and the auditor flagged it as a critical finding because it could allow contaminated air to flow into the aseptic area.

Documentation is where many factories slip up. UNIHF auditors review batch production records (BPRs) for at least three recent batches of the same peptide product. They check that each BPR includes the master formula, equipment used, in-process controls, and signatures at every step. The auditor also looks for deviations—if a batch had a temperature excursion during synthesis, there must be a deviation report with root cause analysis and corrective actions. In one audit, we found that a factory’s BPR for a 15-mer peptide had a missing signature for the cleavage step, and the auditor required the factory to issue a corrective action within 24 hours. The factory also had to provide a list of all batches produced in the last six months and the corresponding deviation reports.

Equipment calibration and maintenance records are another must-check. The auditor requests calibration certificates for all critical instruments—HPLC, pH meters, balances, thermometers, and pressure gauges. Calibration must be traceable to national or international standards (like NIST), and the frequency must be at least every 12 months for most instruments. For example, a balance used for weighing peptide raw materials must have a readability of 0.1 mg and be calibrated with certified weights. The auditor also checks the maintenance logs for lyophilizers, autoclaves, and cleanroom HVAC systems. If a lyophilizer’s compressor was replaced six months ago but the maintenance log doesn’t show a re-qualification run, that’s a gap. The auditor will ask for the re-qualification data, including the temperature distribution map and vacuum hold test results.

Stability testing is a key differentiator for peptide manufacturers. UNIHF auditors ask for the stability study protocol for the factory’s top-selling peptide product. The study should include at least three time points (0, 3, and 6 months) under accelerated conditions (40°C ± 2°C, 75% RH ± 5% RH) and long-term conditions (25°C ± 2°C, 60% RH ± 5% RH). The assay must remain within 90-110% of the initial value, and the impurity profile must not increase by more than 1%. If the factory has no stability data for a product that’s been on the market for over a year, that’s a major concern. In one audit, we found that a factory’s stability study for a peptide used in research showed a 5% drop in assay after six months at 25°C, which indicated poor formulation. The auditor recommended the factory reformulate the product with a different buffer system or lyophilization cycle.

Supplier qualification is also audited. UNIHF checks that the factory has a list of approved suppliers for all raw materials and that each supplier is evaluated based on quality, delivery, and price. The auditor requests the supplier audit reports for the top three raw material vendors. If the factory hasn’t audited a supplier in the last two years, that’s a gap. The auditor also reviews the incoming inspection records for raw materials—each batch must be tested for identity, purity, and moisture content. For example, a batch of Fmoc-Arg(Pbf)-OH must have a purity of at least 99.0% by HPLC, and the moisture content must be below 1.0% by Karl Fischer. If the factory accepts a batch with 98.5% purity without a deviation report, the auditor will flag it.

Finally, the auditor checks the factory’s recall and complaint handling procedures. The factory must have a written procedure for handling product complaints, including a timeline for response (typically 24 hours for initial acknowledgment) and a root cause investigation. The auditor reviews the last three complaints and the corresponding corrective actions. If a complaint about a peptide’s solubility was not investigated within 30 days, that’s a finding. The factory also needs a recall procedure that includes a mock recall exercise every two years. In one audit, we found that the factory’s mock recall took 48 hours to identify 90% of the affected product, which was acceptable, but the auditor recommended reducing the time to 24 hours.

For a more detailed breakdown of how UNIHF Technology Services approaches these audits, including specific checklists and data points, check out the Guangdong Factory Audit UNIHF Technology Services page, which provides a step-by-step guide to the audit process, including sample reports and common findings.